Hernia Repair Devices Global Market is estimated to be worth $4.4 billion by 2027
Hernia is a protrusion of internal organs or tissues through structure or muscle, it occurs most commonly in the abdominal region. Hernia is mainly caused by a combination of pressure and excessive muscular strain, weakness or injury of the abdominal wall. Generally, small or large intestine or intra-abdominal fat protrudes through the weakened abdominal wall. There are various types of hernias classified based on their anatomical locations into inguinal, incisional, umbilical and other type of hernias. The most common symptoms are pain, swelling, or a bulge and they can develop into an emergency if the hernia is strangulated. Surgery is the gold standard method of treatment for most hernias, where hernia repair devices (meshes) are used for the treatment through open surgery, laparoscopic surgery, or robotic surgical techniques. Globally, around 20 million hernia procedures are performed every year, of which close to XX million surgeries are performed using hernia meshes.
According to IQ4I analysis, the hernia repair devices global market is estimated to grow at a low single digit CAGR to reach $4,400.1 million by 2027. Increasing demand for minimally invasive procedures, growing number of patients suffering from obesity and other lifestyle diseases who are vulnerable to develop hernia, and the rise in the aging population are the factors driving the growth of the market. However, inconsistent reimbursements and high cost of the hernia repair procedure, high implementation cost and stringent regulations for approval of hernia repair devices are restraining the growth of the market.
The hernia repair devices global market is segmented based on products, hernia types, repair types, end-users and geography. Among the products, hernia repair mesh segment occupied the largest share of the hernia repair global market and is expected to grow at a low single-digit CAGR from 2020 to 2027 owing to increase in adoption of meshes which results in the lower recurrence rate of hernia as compared to the repair without meshes.
Among hernia types, inguinal hernia held the largest market share in 2020 and incisional hernia is expected to grow at low single-digit CAGR from 2020 to 2027. Incisional hernia occurs in persons who have undergone prior abdominal surgery, traumatic abdominal wall injuries and due to change in lifestyle, there is a rise in the number of C-sections performed thereby increasing the risk for incisional hernia incidence and hence driving the incisional hernia market.
In hernia repair market by repair types, the open tension-free repair generated the largest revenue in 2020 and robotic-assisted surgery is expected to grow at a high single-digit CAGR from 2020 to 2027 due to increasing adoption of minimally invasive hernia repair procedures, increasing demand for better clinical outcomes, benefits associated with the techniques such as quick recovery, less hospital stays and lower infection rates.
Among the end-users segment, the hospitals dominated with largest revenue in 2020 as most of the hernia repair procedures are carried here. Ambulatory surgical centers are expected to grow at mid single-digit CAGR from 2020 to 2027 by 2027, as advancement in technologies now enable the ambulatory surgical centers to perform procedures utilizing minimally invasive technology and novel prosthetic devices. Thus, the ambulatory surgical centers are expected to reduce post-operative complications, cost and long stays in the hospitals.
Geographically, North America region held the largest share of the hernia repair devices global market in 2020 due to highly advanced healthcare facilities, increase in awareness about the advanced technologies, availability of Medicare and third-party insurance facilities, and easy availability of skilled personnel are driving the market growth. Asia-Pacific is expected to grow at a mid single-digit CAGR from 2020 to 2027 due to rising adoption of tension-free repair procedures, increasing access to advanced healthcare technology and affordability and increase in population who are vulnerable to develop hernia.
In 2020, the number of hernia surgeries performed are estimated to be XX and there is a reduction in number of procedures performed as compared to 2019 (XX) because the healthcare resources are being diverted to deal with the COVID-19 pandemic and most of the elective surgeries have been suspended and only emergency cases are being operated thereby hindering the growth of the market.
Factors such as increasing instances of infection, recurrences, adverse reaction such as inflammation, and pain associated with synthetic meshes, reduced mechanical strength and graft rejection in case of biological meshes have led to the development of composite meshes by manufacturers that address various issues and this segment is projected to have high growth in the future.
Technological advancements such as introduction of meshes coated with antibiotics to reduce the rate of infection (Gore dual mesh biomaterial), and drug-eluting hernia meshes developed by Ariste Medical (U.S.) which elutes sirolimus at the hernia site to reduce the infection rate are being developed. Further, BD has come up with new technology for simplifying minimally invasive ventral hernia mesh placement and the device Phasix ST Mesh with Echo 2 Positioning System which is absorbable with a removable positioning system and the product has received 510(k) clearance in November 2019. Similarly, in October 2019, Exogenesis Corp, received FDA 510(K) clearance for Exogenesis Hernia Mesh, an innovative implant intended for soft tissue repair which possesses a unique nanometer-level surface texture, enabling favorable post implant tissue compatibility via the application of Accelerated Neutral Atom Beam (ANAB) technology during manufacturing. Similarly, On August 11, 2020, Deep Blue Advances launched T-line Hernia Mesh with integrated suture-like extensions, which provide superior anchoring strength and eliminates key point of failure for conventional mesh fixation.
The average selling price of meshes is estimated to range from $XX - $XX in emerging and underdeveloped countries to developed countries, and the total addressable procedural volume for hernia repair is estimated to be XX in 2020 with the penetration rate of XX% for surgeries performed using meshes, there is an ample opportunity for the growth of global hernia repair market.
Some of the major companies operating in the hernia repair devices market are Becton, Dickinson and Company, (U.S.), Medtronic, PLC., (Ireland), Allegan (U.S.), Cook Medical (U.S.), Johnson & Johnson (Ethicon) (U.S.), B. Braun Melsungen AG (Germany), W. L. Gore & Associates, Inc. (U.S.), and Insightra Medical, Inc. (U.S.).